Syngene International Allots 7.29 Lakh Equity Shares Under Employee Incentive Plan
Syngene International has completed the allotment of 7,29,727 equity shares to its Employee Welfare Trust under the Long Term Incentive Performance Share Unit Plan 2023, with Board approval received on April 29, 2026. The shares were issued at par value of Rs. 10 with no premium, increasing the total paid-up share capital to Rs. 403,66,91,470. The newly allotted shares rank pari-passu with existing equity shares and are listed on both NSE and BSE with no lock-in restrictions.

*this image is generated using AI for illustrative purposes only.
Syngene International has announced the allotment of 7,29,727 equity shares to the Syngene Employee Welfare Trust under the Syngene Long Term Incentive Performance Share Unit Plan 2023. The Board of Directors approved the allotment at its meeting held on April 29, 2026, in accordance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and Regulation 10(c) of the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021.
Share Capital Impact
Consequent to the allotment, the company's paid-up share capital has increased from Rs. 402,93,94,200, comprising 40,29,39,420 equity shares of Rs. 10 each, to Rs. 403,66,91,470, comprising 40,36,69,147 equity shares of Rs. 10 each. The shares have been allotted at an exercise price of Rs. 10 per share with no premium.
Key Allotment Details
| Particulars: | Details |
|---|---|
| Number of shares issued: | 7,29,727 equity shares |
| Date of issue: | April 29, 2026 |
| Par value per share: | Rs. 10/- |
| Exercise price per share: | Rs. 10/- |
| Premium per share: | Nil |
| Distinctive numbers: | 40,29,39,421 to 40,36,69,147 |
| Total issued shares post-allotment: | 40,36,69,147 shares |
| Total issued share capital post-allotment: | Rs. 403,66,91,470 |
Regulatory Compliance and Listing
The equity shares allotted pursuant to the exercise of Performance Share Units rank pari-passu with the existing equity shares of the company. The shares are listed on both the National Stock Exchange of India Limited and BSE Limited. The company has confirmed that listing fees have been paid, and there is no lock-in applicable to the allotted shares.
Previous Approvals
The regulatory filing reveals that the company had previously received approvals for share allotments under the same plan. For 22,00,000 equity shares, BSE approval was received on July 26, 2023, and NSE approval on the same date. For an additional 45,29,000 equity shares, both exchanges provided approval on August 22, 2025.
Historical Stock Returns for Syngene International
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +8.21% | +7.27% | +12.52% | -29.06% | -25.64% | -18.75% |
How will the dilution from 7.29 lakh new shares impact Syngene's earnings per share and market valuation in the coming quarters?
What performance metrics must employees meet under the 2023 Long Term Incentive Plan to exercise their remaining share units?
Will Syngene expand its employee stock ownership programs further as the company scales its operations and workforce?


































